Automate Your Wheel Strategy on HUM
With Tiblio's Option Bot, you can configure your own wheel strategy including HUM - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HUM
- Rev/Share 1022.4658
- Book/Share 151.9455
- PB 1.65
- Debt/Equity 0.6902
- CurrentRatio 1.9522
- ROIC 0.0547
- MktCap 30157559910.0
- FreeCF/Share 20.2566
- PFCF 12.3647
- PE 19.0898
- Debt/Assets 0.2499
- DivYield 0.0142
- ROE 0.0902
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
Upgrade | HUM | Raymond James | Market Perform | Outperform | -- | $315 | May 1, 2025 |
Initiation | HUM | KeyBanc Capital Markets | -- | Sector Weight | -- | -- | Oct. 11, 2024 |
Upgrade | HUM | Bernstein | Market Perform | Outperform | -- | $308 | Oct. 8, 2024 |
Downgrade | HUM | TD Cowen | Buy | Hold | $402 | $261 | Oct. 7, 2024 |
Downgrade | HUM | Jefferies | Buy | Hold | $519 | $253 | Oct. 7, 2024 |
Downgrade | HUM | Piper Sandler | Overweight | Neutral | $392 | $274 | Oct. 3, 2024 |
Downgrade | HUM | Leerink Partners | Outperform | Market Perform | $400 | $250 | Oct. 2, 2024 |
Downgrade | HUM | Stephens | Overweight | Equal Weight | $400 | $250 | Oct. 2, 2024 |
Downgrade | HUM | BofA Securities | Neutral | Underperform | $376 | $247 | Oct. 2, 2024 |
News
Humana, Inc. (HUM) Q4 2024 Earnings Call Transcript
Published: February 11, 2025 by: Seeking Alpha
Sentiment: Neutral
Humana, Inc. (NYSE:HUM ) Q4 2024 Earnings Conference Call February 11, 2025 9:00 AM ET Company Participants Lisa Stoner - VP, IR James Rechtin - President, CEO & Director Celeste Mellet - CFO George Renaudin - President, Insurance Conference Call Participants Ann Hynes - Mizuho Justin Lake - Wolfe Research Sarah James - Cantor Fitzgerald Joshua Raskin - Nephron Research A.J. Rice - UBS Ben Hendrix - RBC Capital Markets Whit Mayo - Leerink Partners Erin Wright - Morgan Stanley Scott Fidel - Stephens George Hill - Deutsche Bank Ryan Langston - TD Cowen Andrew Mok - Barclays Operator Good …
Read More
Humana Stock Drops as Medicare Advantage Members Expected to Decline
Published: February 11, 2025 by: Investopedia
Sentiment: Negative
Humana (HUM) shares slid after the health insurer said it expects Medicare Advantage memberships to decline in 2025.
Read More
Humana (HUM) Reports Q4 Loss, Tops Revenue Estimates
Published: February 11, 2025 by: Zacks Investment Research
Sentiment: Negative
Humana (HUM) came out with a quarterly loss of $2.16 per share versus the Zacks Consensus Estimate of a loss of $2.26. This compares to loss of $0.11 per share a year ago.
Read More
Humana 2024 Profits Hit $1.2 Billion As Insurer Leaves Unprofitable Medicare Markets
Published: February 11, 2025 by: Forbes
Sentiment: Positive
Humana Tuesday reported $1.2 billion in 2024 profits that included a $693 million fourth quarter loss as the health insurer exits unprofitable Medicare Advantage markets for 2025.
Read More
About Humana Inc. (HUM)
- IPO Date 1981-12-31
- Website https://www.humana.com
- Industry Medical - Healthcare Plans
- CEO James A. Rechtin
- Employees 65680